Stay up to date with our newsletter

Get in touch!

What can we do to help?

I would like to:

Lets start the conversation!

Sign up to our newsletter

View open positions on our Careers page,
or connect with us on Linkedin Twitter Facebook

Thank you!
We will be in touch shortly.

2019.12.18

Jay Stella joins Sai Life Sciences as Chief Business Officer

Jay Stella

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for the company. Jay will be based out of Cambridge, Massachusetts, United States and report to the CEO & Managing Director, Krishna Kanumuri.

Jay Stella brings over 25 years of leadership in the pharmaceutical and medical devices industries with extensive experience across R&D, Manufacturing, Business Development, Finance, and Post-M&A Integrations. He held positions of increasing responsibility at Millennium Pharmaceuticals and Takeda Pharmaceuticals for 15 years, across strategy & operations, business development, and integrations & divestitures, while also gaining significant experience in the Japanese cultural and business environment. Earlier, he worked for medium sized biotech companies, Biogen and Genetics Institute, where he held various financial and operational roles. Prior to the pharmaceutical industry, Jay worked in technical operations, manufacturing, planning, and strategic sourcing roles in the medical device industry. Jay received his MBA from Boston University and his Baccalaureate degree from the University of Vermont in Spanish with minors in Chemistry and Biology.

Making the announcement, Krishna Kanumuri said, “Inducting top-notch global leadership and scientific talent is a key priority as part of our transformative effort, Sai Nxt. We are delighted to have Jay on board in this exciting phase.”

Sai Nxt is an organization-wide initiative aimed at transforming the company into a new generation CDMO. With investments of over US $ 150 million between 2019 and 2023, the transformation focus is on three key areas – People & culture, Processes & automation, Infrastructure & scientific capabilities.

Commenting on his appointment, Jay Stella said, “I am very excited to join Sai Life Sciences at this pivotal point in the company’s journey. Sai’s vision to support global innovators bring 25 new medicines to life by 2025 is an inspiring one, and I look forward to playing a part in achieving it.”

News

2020.04.02

Sai Life Sciences becomes first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI)

Sai Life Sciences becomes first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI)

Sai Life Sciences, today announced its induction into the Pharmaceutical Supply Chain Initiative (PSCI) membership as an ‘Associate Member’. Welcoming Sai Life Sciences into its fold, a PSCI spokesperson said, “PSCI and its members are delighted to welcome Sai Life Sciences into membership, PSCI’s first member with its main headquarters in India. We are pleased […]
Read more

2020.04.01

Making sanitizers available during COVID-19 outbreak

Making sanitizers available during COVID-19 outbreak

Over the past few weeks since the outbreak of COVID-19, there’s been a sudden rise in sanitization efforts by various public and private organizations to help arrest the spread of the disease. This, along with efforts of individuals in their own spaces, has created a huge demand for effective alcohol-based sanitizers to aid the sanitization […]
Read more

2020.03.02

ISO 14001:2015 & ISO 45001:2018

Sai Life Sciences receives ISO 14001:2015 and ISO 45001:2018 certification

Sai Life Sciences received the ISO 14001:2015 (Environment management system) and ISO 45001:2018 (Occupational health and safety management system) certification for its R&D centre (Unit II), Manufacturing facility (Unit IV) and Corporate office. Certified by Bureau Veritas, it reflects the organization’s commitment towards continually improving its health, safety & environment performance. Responding to the development, […]
Read more

2020.02.25

2nd SCMPro India Procurement Leadership Forum & Awards 2020

Sai Life Sciences SCM shines with awards in Supply Risk and Supplier Relationship Management

Sai Life Sciences won two awards at the recently concluded 2nd SCMPro India Procurement Leadership Forum & Awards 2020, in the categories of Supply Risk Management and Supplier Relationship Management. The awards were selected by a panel of eminent academicians and industry leaders to recognize organizations and individuals who exhibit outstanding approaches in creating compliant […]
Read more

2020.02.19

Dean Edney

Accomplished scientific leader and GSK veteran, Dean Edney joins Sai Life Sciences

Sai Life Sciences, today announced the appointment of Dr. Dean Edney as Senior Vice President and Global Head of Process Research & Development. An accomplished scientific leader and industry veteran with over 25 years of experience in small molecule pharmaceutical process and product development, Dean Edney will split his time between the company’s R&D centre […]
Read more